OCRA News
Our Community Needs YOU | Heroes Highlights
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and fun!) as turning your favorite activity into a fundraiser…
Study Finds Pfizer-BioNTech COVID-19 Vaccine Safe and Effective for Gynecologic Oncology Patients
A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the time of their…
PARP Inhibitors and Ovarian Cancer
Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer…
The Overview | January 2022
Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community…
OCRA Awards Two Ovarian Cancer Research Prizes
OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research and commitment to future discoveries. Dr…
Commitments to Make in the New Year That Support OCRA
It’s a new year, and there’s no better time to commit to simple actions that can make a big impact! So simple, that they take between one minute and half an hour to complete. Set OCRA as your AmazonSmile charity of choice…
OCRA-Funded Research Points to Potential for Predicting Ovarian Cancer
New study findings not only reveal where the most common ovarian cancer subtype originates in certain patients, but also point to the future possibility of being able to predict who will get the disease…
Acupuncture for Pain Management
Finding ways to minimize the pain caused by ovarian cancer can have a major impact on maximizing the quality of life for those dealing with this illness…
Even More Ways to Stay Connected and Get Support
OCRA is pleased to announce the offering of an additional four groups to our Staying Connected online support group series…
Hereditary Breast and Ovarian Cancer Syndrome (HBOC)
Hereditary breast and ovarian cancer syndrome, known as HBOC, refers to a predisposition to develop cancer that is passed down through the generations of a family. HBOC is inherited in the form of a harmful mutation, or change, in a gene…
OCRA Awards Nearly $6.5 Million in Ovarian Cancer Research Grants
More breakthroughs are on the horizon, as OCRA has awarded grants to 22 dedicated scientists at 15 prestigious medical institutions to enable future ovarian cancer discoveries…
Secondary Cytoreductive Surgery Post-Recurrence Results in Longer Overall Survival
A randomized trial recently showed that patients with an ovarian cancer recurrence who undergo cytoreductive surgery along with chemotherapy show better survival rates than those who only receive chemotherapy…